Charmin has unveiled its newest product: A toilet paper roll that stretches as tall as the Washington Monument. Now available nationwide online and in store, the Forever Roll, gives consumers "a ...

Detailed Financial Analysis OGE Energy continues to experience robust load growth, particularly in the commercial segment, which expanded by an impressive 25% on a weather-normalized basis. This ...

An ultra-strong substance is being used to surface roads in a revolutionary trial - and it could spell the end of potholes. There have been "dramatic improvements" to the quality of roads treated with ...

Why it matters: Intel's new chips are more than technical upgrades – they're a statement. With Core Ultra 3 and Xeon 6+, built partly on its breakthrough 18A process, Intel is betting it can regain ...

Net Earnings: $151.8 million or $1.35 per diluted share for Q4 2025. Adjusted Earnings: $155 million or $1.37 per diluted share for Q4 2025. Core EBITDA: $291.4 million for Q4 2025, a 33% increase ...

GE Aerospace has reported an impressive third quarter for 2025, surpassing market expectations in terms of revenue and earnings per share. The company has also updated its guidance for the full year, ...

Researchers have pioneered a 3D printing method that grows metals and ceramics inside a water-based gel, resulting in exceptionally dense, yet intricate constructions for next-generation energy, ...

Palm Jumeirah accounted for 34 per cent of all prime residential transactions during the quarter, making it the most active area. Image: Shutterstock Dubai’s high-end residential market recorded a ...

FOOTHILL RANCH, Calif., October 07, 2025--(BUSINESS WIRE)--TAE Life Sciences (TLS), a leader in Boron Neutron Capture Therapy (BNCT), today announced key milestones demonstrating commercial traction, ...

Chaiiwala has filed a trading update for the year to 31 December 2024 (image credit: Chaiiwala) An Indian street food brand with more than 100 locations across the UK has reported an increase in sales ...

Axsome Therapeutics is transitioning into a leading neuroscience company with three marketed drugs and a robust late-stage pipeline. Q2 2025 saw 72% YoY revenue growth, driven by Auvelity and Sunosi, ...

An ultra-strong substance is being used to surface roads in a revolutionary trial – and it could spell the end of potholes. There have been “dramatic improvements” to the quality of roads treated with ...